Upgrade to SI Premium - Free Trial

Edgewise Therapeutics (EWTX) PT Raised to $59; RBC Capital: 'We would be buyers on weakness'

June 17, 2026 6:47 AM
(Updated - June 17, 2026 7:43 AM EDT)

RBC Capital analyst Leonid Timashev raised the price target on Edgewise ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Hot Comments